drug · small molecule
TOFACITINIB CITRATE
Phase 1updated 3mo agoby $SIGY Sigyn Therapeutics, Inc.🔗 ChEMBL
Phase 1community read0 votes
🐶 often sniffed alongside
top 8- tagApproval222 co-mentions · 60 sources
- drugXELJANZ XR213 co-mentions · 60 sources
- drugXELJANZ213 co-mentions · 60 sources
- drugtofacitinib ER111 co-mentions · 60 sources
- drugtofacitinib citrate ER111 co-mentions · 60 sources
- drugtofacitinib111 co-mentions · 60 sources
- tagSmall Molecule111 co-mentions · 60 sources
- companyAjanta Pharma Ltd7 co-mentions · 7 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for rheumatoid arthritis and psoriatic arthritis and 4 investigational indications.
targets
Janus Kinase (JAK)
all catalysts(0)
nothing on the calendar yet
Trials studying TOFACITINIB CITRATE
- phase2A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
- phase2Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis
- phase2Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that